Polarean Imaging Ltd (POLX) ORD GBP0.00037
1.00p
(4.00%)
- Add to watchlist
- Create an alert
- This stock can be held in a
1.00p
(4.00%)
1.00p
(4.00%)
Share news, reports & tips
-
Polarean Imaging enrolls first patient in Phase III study at University of Cincinnati
5 August 2019 08:32
(Sharecast News) - Medical-imaging technology company Polarean has enrolled its first patient in the third trial of its proprietary drug-device combination product at the University of Cincinnati.
-
Polarean Imaging revenues climb as clinical trial nears completion
27 June 2019 10:02
(Sharecast News) - Polarean Imaging's shares climbed on Thursday after reporting that its annual revenues doubled to come in slightly above expectations as sales in the US soared.
-
Polarean names Charles Osborne as new CFO
29 April 2019 09:24
(Sharecast News) - Clinical stage medical-imaging technology outfit Polarean tapped former Innocrin Pharmaceuticals finance boss Charles Osborne Jr to take over as its chief financial officer on Monday.
-
Polarean Imaging enters contract with University of British Columbia
15 February 2019 10:27
(Sharecast News) - Medical imaging technology company Polarean Imaging has entered into a contract for the procurement of its latest polariser system by the University of British Columbia, it announced on...
-
Tuesday broker round-up
11 December 2018 13:41
(Sharecast News) - ASOS: Morgan Stanley downgrades to underweight with a target price of 3,200p.
-
Polarean Imaging progresses to Phase III trial of hyperpolarised 129-Xenon
23 August 2018 14:53
(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Thursday that the first patient has been enrolled in its Phase III FDA clinical trial, which aims to demonstrate...
-
Polarean upbeat on results of pilot study
27 July 2018 09:26
(Sharecast News) - Medical imaging technology company Polarean Imaging announced the allowance of the latest patents on polarisation, the results of a 'pilot study' that was undertaken in...
Company announcements Announcements
-
Statement on Amphion Innovations
9 August 2019 16:14
Amphion Innovations
-
Phase III Clinical Trials update
5 August 2019 07:00
Polarean Imaging
-
Total Voting Rights
31 July 2019 10:04
Polarean Imaging
-
Holding(s) in Company
30 July 2019 15:18
Amati AIM Vct
-
Holding(s) in Company
30 July 2019 14:25
Polarean Imaging
-
Holding(s) in Company
29 July 2019 17:31
Polarean Imaging
-
Result of AGM
25 July 2019 15:31
Polarean Imaging
-
Exercise of Warrants
24 July 2019 14:45
Polarean Imaging
-
Placing to raise £2.1 million
22 July 2019 10:00
Polarean Imaging
-
New System Order
11 July 2019 07:00
Polarean Imaging
-
Investor Symposium presentations available online
13 June 2019 17:02
Polarean Imaging
-
Phase III Clinical Trials - Update
11 June 2019 07:00
Polarean Imaging
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2019. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.